Live Poll Results — Which pricing strategy is specifically encouraged by the Orphan Drug Act to stim
See real-time poll results. Powered by AIPolls.Net.
Pharmaceutical Pricing Puzzles: The Orphan Drug Act Effect
The pharmaceutical industry employs various pricing strategies, particularly for rare disease treatments. The Orphan Drug Act of 1983 fundamentally changed how companies approach medication development for rare conditions. This pricing model has significant implications for healthcare systems, insurance providers, and patients. Test your knowledge about this specialized area of medical product pricing!
Which pricing strategy is specifically encouraged by the Orphan Drug Act to stimulate development of medications for rare diseases?
Poll Type: Trivia | Total Votes: 0
| Option | Votes | Percentage |
|---|---|---|
| {'choice_text': 'Premium pricing with market exclusivity periods, allowing companies to recoup R&D costs from smaller patient populations', 'is_correct': True} | 0 | 0% |
| {'choice_text': 'Penetration pricing with mandated price caps to ensure affordability for patients with rare conditions', 'is_correct': False} | 0 | 0% |
| {'choice_text': 'Reference-based pricing where orphan drug costs must align with comparable non-orphan treatments', 'is_correct': False} | 0 | 0% |
| {'choice_text': 'Value-based contracting requiring pharmaceutical companies to prove efficacy before full payment', 'is_correct': False} | 0 | 0% |